Coxsackie A Virus Antibodies, CSF
UDP Glucuronosyltransferase 2B15 (UGT2B15) Genotyping
Spinocerebellar Ataxia Type 2 (ATXN2) Gene Mutation Analysis
Listeria Antibody, CSF
Complement Component C3, Nephritic Factor
Iduronate-2-sulfatase
Sphingomyelin Phosphodiesterase 1 (SMPD1) Mutation Analysis, Niemann-Pick Disease
Selenium, Random, Urine
Carnitine, Total, Urine
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Diseases (4)
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now
Loading...